• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发兰加特病毒感染性克隆作为蜱传脑炎减毒活疫苗的平台。

Development of Langat virus infectious clones as a platform for live-attenuated tick-borne encephalitis vaccine.

作者信息

Asghar Naveed, Jaafar Rita, Valko Anna, Merinder Olivia, Ljungberg Karl, Lindqvist Carl Mårten, Johansson Magnus

机构信息

School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Scantox Sweden, Solna, Sweden.

出版信息

Npj Viruses. 2025 May 23;3(1):44. doi: 10.1038/s44298-025-00129-6.

DOI:10.1038/s44298-025-00129-6
PMID:40410304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12102213/
Abstract

Tick-borne encephalitis (TBE) is one of the most important tick-transmitted diseases in Europe and Asia. With no specific antiviral treatment available, vaccination remains the most effective protective strategy for TBE. Unlike currently available inactivated TBE vaccines that require repeated boosters, live-attenuated vaccines could offer lifelong immunity with a single dose. Langat virus (LGTV) is a naturally attenuated strain of TBE virus (TBEV). In this study, we engineered and rescued four infectious clones (ICs) of LGTV using RNA- and DNA-based reverse genetics methods. The ICs rescued by DNA-based method showed higher genetic stability in cell culture. One of the ICs rescued by DNA-based method was further evaluated in vitro and in vivo, which exhibited growth kinetics and immune profile comparable to the LGTV strain in our laboratory. This reverse genetics platform will be utilized to introduce targeted mutations within the LGTV genome to develop a live-attenuated TBE vaccine.

摘要

蜱传脑炎(TBE)是欧亚大陆最重要的蜱传疾病之一。由于没有可用的特异性抗病毒治疗方法,疫苗接种仍然是预防TBE最有效的保护策略。与目前需要多次加强接种的灭活TBE疫苗不同,减毒活疫苗单剂量即可提供终身免疫。兰加特病毒(LGTV)是蜱传脑炎病毒(TBEV)的一种自然减毒株。在本研究中,我们使用基于RNA和DNA的反向遗传学方法构建并拯救了四个LGTV感染性克隆(IC)。基于DNA的方法拯救的IC在细胞培养中显示出更高的遗传稳定性。对基于DNA的方法拯救的其中一个IC进行了进一步的体外和体内评估,其生长动力学和免疫特性与我们实验室中的LGTV毒株相当。这个反向遗传学平台将用于在LGTV基因组中引入靶向突变,以开发一种减毒活TBE疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/ccd507632b8e/44298_2025_129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/f048c5d46415/44298_2025_129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/475377f70633/44298_2025_129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/e6e9c1d0e096/44298_2025_129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/bc75233881c9/44298_2025_129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/ccd507632b8e/44298_2025_129_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/f048c5d46415/44298_2025_129_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/475377f70633/44298_2025_129_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/e6e9c1d0e096/44298_2025_129_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/bc75233881c9/44298_2025_129_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13be/12102213/ccd507632b8e/44298_2025_129_Fig5_HTML.jpg

相似文献

1
Development of Langat virus infectious clones as a platform for live-attenuated tick-borne encephalitis vaccine.开发兰加特病毒感染性克隆作为蜱传脑炎减毒活疫苗的平台。
Npj Viruses. 2025 May 23;3(1):44. doi: 10.1038/s44298-025-00129-6.
2
Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.基于 Langat 病毒遗传骨架构建的靶向稳定且具有高度免疫原性的微小 RNA 的单剂量减毒活疫苗候选物,用于预防蜱传脑炎。
mBio. 2019 Apr 23;10(2):e02904-18. doi: 10.1128/mBio.02904-18.
3
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.交叉反应性抗体可预防小鼠感染致死性蜱传脑炎病毒。
Front Immunol. 2023 Feb 28;14:1134371. doi: 10.3389/fimmu.2023.1134371. eCollection 2023.
4
Single-dose vaccine against tick-borne encephalitis.蜱传脑炎的单剂疫苗。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13103-8. doi: 10.1073/pnas.1306245110. Epub 2013 Jul 15.
5
A tick-borne encephalitis model in infant rats infected with langat virus.感染兰加特病毒的幼鼠蜱传脑炎模型。
J Neuropathol Exp Neurol. 2014 Dec;73(12):1107-15. doi: 10.1097/NEN.0000000000000131.
6
Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.I型干扰素通过全身和局部抗病毒反应保护小鼠免受Langat病毒致命的嗜神经感染。
J Virol. 2014 Nov;88(21):12202-12. doi: 10.1128/JVI.01215-14. Epub 2014 Aug 13.
7
MicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.基于微小RNA对蜱传黄病毒神经发病机制的调控:挑战与展望。
Antiviral Res. 2016 Mar;127:57-67. doi: 10.1016/j.antiviral.2016.01.003. Epub 2016 Jan 19.
8
Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.嵌合蜱传脑炎病毒减毒株ChinTBEV的构建与鉴定
Methods Mol Biol. 2016;1403:285-93. doi: 10.1007/978-1-4939-3387-7_15.
9
Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.基于欧洲型的现有疫苗对远东和西伯利亚型蜱传脑炎(TBE)病毒的免疫原性:系统评价和荟萃分析。
Hum Vaccin Immunother. 2014;10(10):2819-33. doi: 10.4161/hv.29984.
10
A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.蜱传脑炎疫苗在欧洲的有效性的系统文献回顾。
Vaccine. 2023 Nov 13;41(47):6914-6921. doi: 10.1016/j.vaccine.2023.10.014. Epub 2023 Oct 17.

本文引用的文献

1
Publicly available surveillance data on tick-borne encephalitis in Europe, 2023.2023年欧洲蜱传脑炎公开监测数据。
Ticks Tick Borne Dis. 2024 Nov;15(6):102388. doi: 10.1016/j.ttbdis.2024.102388. Epub 2024 Aug 13.
2
Serial cell culture passaging led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain.连续细胞传代导致一种强毒猪德尔塔冠状病毒株的完全衰减和特征变化。
J Virol. 2024 Aug 20;98(8):e0064524. doi: 10.1128/jvi.00645-24. Epub 2024 Jul 16.
3
Tick-Borne Encephalitis-Review of the Current Status.
蜱传脑炎——现状综述
J Clin Med. 2023 Oct 18;12(20):6603. doi: 10.3390/jcm12206603.
4
A Perspective on Current Flavivirus Vaccine Development: A Brief Review.当前黄病毒疫苗开发的观点:简要综述。
Viruses. 2023 Mar 28;15(4):860. doi: 10.3390/v15040860.
5
Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.蚊虫传播的黄病毒疫苗研发的最新进展
Viruses. 2023 Mar 23;15(4):813. doi: 10.3390/v15040813.
6
Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020.2012 年至 2020 年欧盟/欧洲经济区蜱传脑炎的时空传播。
Euro Surveill. 2023 Mar;28(11). doi: 10.2807/1560-7917.ES.2023.28.11.2200543.
7
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection.交叉反应性抗体可预防小鼠感染致死性蜱传脑炎病毒。
Front Immunol. 2023 Feb 28;14:1134371. doi: 10.3389/fimmu.2023.1134371. eCollection 2023.
8
Rescue and in vitro characterization of a divergent TBEV-Eu strain from the Netherlands.从荷兰分离到一株分化的 TBEV-Eu 株并进行了拯救和体外鉴定。
Sci Rep. 2023 Feb 18;13(1):2872. doi: 10.1038/s41598-023-29075-0.
9
An Experimental Murine Model to Study Acquisition Dynamics of Tick-Borne Langat Virus in .一种用于研究蜱传兰加特病毒感染动力学的实验性小鼠模型
Front Microbiol. 2022 Apr 14;13:849313. doi: 10.3389/fmicb.2022.849313. eCollection 2022.
10
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).武田公司登革热候选疫苗(TAK-003)的 3 年疗效和安全性。
Clin Infect Dis. 2022 Aug 24;75(1):107-117. doi: 10.1093/cid/ciab864.